In conjunction with Cantor’s Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference, Pharmaceuticals & Biotech Analysts Chen, Kim and Brayer, along with Drs. Ashraf, Chacon and Galimberti, discuss key new treatments in aesthetic dermatology at a luncheon meeting to be held in Miami on December 8 at 12:15 pm hosted by Cantor Fitzgerald.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on APLS:
- Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
- Apellis Pops After FDA Accepts NDA Amendment For Drug
- Apellis Announces FDA Acceptance of NDA Amendment and New PDUFA Date of February 26, 2023 for Pegcetacoplan for Geographic Atrophy (GA)
- Apellis downgraded to Hold from Buy at Jefferies